{"corpus_id":237615167,"paper_sha":"34f3bab33094fee2ddd5f57b91aa8b9959115e50","doi":"10.1002/bmc.5248","arxiv_id":null,"pmid":34555192,"pmcid":null,"mag_id":null,"dblp_id":null,"acl_id":null,"title":"A rapid and sensitive LC-MS/MS method for the determination of vanillic acid in rat plasma with application to pharmacokinetic study.","year":2021,"publication_date":"2021-09-23","venue":"Biomedical chromotography","journal":{"name":"Biomedical chromatography : BMC","pages":"\n          e5248\n        ","volume":null},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article"],"s2_fields_of_study":["Medicine","Chemistry"],"reference_count":14,"citation_count":15,"influential_citation_count":1,"is_open_access":false,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Animals","mj":false,"ui":"D000818"},{"d":"Biological Availability","mj":false,"ui":"D001682"},{"d":"Chromatography, High Pressure Liquid","mj":false,"qs":[{"q":"methods","mj":true,"ui":"Q000379"}],"ui":"D002851"},{"d":"Limit of Detection","mj":false,"ui":"D057230"},{"d":"Linear Models","mj":false,"ui":"D016014"},{"d":"Male","mj":false,"ui":"D008297"},{"d":"Rats","mj":false,"ui":"D051381"},{"d":"Rats, Sprague-Dawley","mj":false,"ui":"D017207"},{"d":"Reproducibility of Results","mj":false,"ui":"D015203"},{"d":"Tandem Mass Spectrometry","mj":false,"qs":[{"q":"methods","mj":true,"ui":"Q000379"}],"ui":"D053719"},{"d":"Vanillic Acid","mj":false,"qs":[{"q":"blood","mj":true,"ui":"Q000097"},{"q":"chemistry","mj":false,"ui":"Q000737"},{"q":"pharmacokinetics","mj":true,"ui":"Q000493"}],"ui":"D014641"}],"chemicals":[{"n":"Vanillic Acid","ui":"D014641","reg":"GM8Q3JM2Y8"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":null,"s2_open_access_landing_url":null,"s2_open_access_license":null,"s2_open_access_status":null,"pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Vanillic acid, a phenolic compound isolated from Angelica sinensis and green tea, exhibits excellent antioxidant and anti-inflammatory activities. In this study, a rapid and sensitive ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-ESI-MS/MS) method was established and validated for the determination of vanillic acid in rat plasma. Plasma samples were prepared by protein precipitation with acetonitrile. Chromatographic separation was performed on a ZORBAX RRHD Eclipse Plus C18 column (2.1 × 100 mm, 1.8 μm) with gradient elution at a flow rate of 0.3 mL/min, using mobile phase consisting of 0.1% formic acid (A) and acetonitrile (B). Vanillic acid and caffeic acid (internal standard, IS) were quantified by multiple reaction monitoring (MRM) in negative ion mode. The method was fully validated according to the FDA guidelines. The calibration curve was linear over the range of 2-1000 ng/mL with correlation coefficient more than 0.99. The carry-over, matrix effect, extraction recovery, dilution effect, intra and inter-day precision and the accuracy were within acceptable limits. The method was then applied to pharmacokinetic study of vanillic acid in rats. After oral administration at doses of 2, 5, 10 mg/kg, the plasma concentration reached the peak of 0.42 ± 0.09, 0.73 ± 0.21, 0.92 ± 0.28 μg/mL at the time of 0.55-0.64 h, respectively. The oral bioavailability (F) was calculated as 25.3-36.2 % in rat plasma. The result provided pre-clinical information for further application of vanillic acid.","claims":[{"public_id":"cl_94b53996228195c4439fe5e63b7d82b2","status":"active","text":"A rapid and sensitive UHPLC-ESI-MS/MS method was established and validated for determining vanillic acid in rat plasma.","confidence":0.99,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_94b53996228195c4439fe5e63b7d82b2"},{"public_id":"cl_0ca448f7e12682a4479dfaf79901c7b8","status":"active","text":"After oral dosing, vanillic acid reached peak plasma concentrations of 0.42 ± 0.09, 0.73 ± 0.21, and 0.92 ± 0.28 μg/mL at 0.55-0.64 h, and the calculated oral bioavailability was 25.3-36.2%.","confidence":0.97,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_0ca448f7e12682a4479dfaf79901c7b8"},{"public_id":"cl_9797b61b021f6611e04252d833e95069","status":"active","text":"The calibration curve was linear from 2 to 1000 ng/mL with correlation coefficient greater than 0.99, and carry-over, matrix effect, extraction recovery, dilution effect, precision, and accuracy met acceptable limits.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_9797b61b021f6611e04252d833e95069"},{"public_id":"cl_437cb1f7c0ee0d7b8a9acb964294b0c7","status":"active","text":"The method was successfully applied to a pharmacokinetic study of vanillic acid in rats after oral administration at 2, 5, and 10 mg/kg.","confidence":0.96,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_437cb1f7c0ee0d7b8a9acb964294b0c7"}],"concepts":[{"public_id":"co_087be72101358b24d36d7bc2cefb5b15","status":"active","name":"peak plasma concentration","description":"The maximum measured concentration of vanillic acid in plasma after dosing.","types":["pharmacokinetic parameter"],"aliases":["Cmax"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_087be72101358b24d36d7bc2cefb5b15"},{"public_id":"co_0b5ad40aa23d82d7bc90cb4d420b9bd9","status":"active","name":"rat plasma","description":"The blood plasma matrix from rats used for analyte measurement and pharmacokinetic analysis.","types":["biological sample"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_0b5ad40aa23d82d7bc90cb4d420b9bd9"},{"public_id":"co_5ba96afd852dd4fb90fbe1bb16deb200","status":"active","name":"oral administration","description":"Delivery of vanillic acid by mouth at specified doses in rats.","types":["administration route"],"aliases":["oral dosing"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_5ba96afd852dd4fb90fbe1bb16deb200"},{"public_id":"co_86c6ac729bde7f0c89e69acd2b7d8257","status":"active","name":"vanillic acid","description":"A phenolic compound from natural sources that was measured in rat plasma in this study.","types":["compound"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_86c6ac729bde7f0c89e69acd2b7d8257"},{"public_id":"co_abd5f00764113f351199c71af6248656","status":"active","name":"FDA guidelines","description":"Regulatory bioanalytical validation criteria used to assess the method.","types":["guideline"],"aliases":["Food and Drug Administration guidelines"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_abd5f00764113f351199c71af6248656"},{"public_id":"co_c8cbcae3c018487237f5f08287e45d52","status":"active","name":"pharmacokinetic study","description":"An in vivo study of how vanillic acid is absorbed and measured over time after dosing.","types":["study type"],"aliases":["pharmacokinetic analysis"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c8cbcae3c018487237f5f08287e45d52"},{"public_id":"co_d8b75613c4142143b2bce84cf183cfeb","status":"active","name":"matrix effect","description":"Interference from co-eluting plasma components that can alter mass spectrometric response.","types":["analytical validation parameter"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_d8b75613c4142143b2bce84cf183cfeb"},{"public_id":"co_e86e7ffc076e1bc7b7d5e9c511a7084f","status":"active","name":"oral bioavailability","description":"The fraction of an orally administered dose reaching systemic circulation.","types":["pharmacokinetic parameter"],"aliases":["F"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_e86e7ffc076e1bc7b7d5e9c511a7084f"},{"public_id":"co_ecdf7fe8e093f22747739720243f73fe","status":"active","name":"UHPLC-ESI-MS/MS method","description":"An ultra-high performance liquid chromatography tandem mass spectrometry assay using electrospray ionization for compound quantification.","types":["analytical method"],"aliases":["LC-MS/MS method"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_ecdf7fe8e093f22747739720243f73fe"},{"public_id":"co_f629faeb848927aca1886e58f08253d0","status":"active","name":"calibration curve","description":"The quantitative relationship between vanillic acid concentration and instrument response.","types":["measurement calibration"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_f629faeb848927aca1886e58f08253d0"}],"external_ids":{"DOI":"10.1002/bmc.5248","ArXiv":null,"PubMed":34555192,"PubMedCentral":null,"MAG":null,"DBLP":null,"ACL":null},"open_access":{"is_open_access":false,"pdf_url":null,"landing_url":"https://sah.borca.ai/papers/237615167","source":null,"pdf_url_source":null,"license":null,"reason":"pdf_url_not_indexed"},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":637772,"paper_uid":"45c94f6c-2621-4114-b8a4-f60dc03756e6","canonical_identity":{"paper_id":637772,"paper_uid":"45c94f6c-2621-4114-b8a4-f60dc03756e6","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/237615167"}